Cargando…
Increased plasma levels of NT-proBNP, Troponin T and GDF-15 are driven by persistent AF and associated comorbidities: Data from the AF-RISK study
Atrial fibrillation (AF) is a progressive disease, and early recognition and management may reflect an important strategy to reduce its disease burden. In this study, we evaluated plasma levels of three biomarkers - N-terminal pro-brain natriuretic peptide (NTproBNP), Troponin-T, and growth differen...
Autores principales: | Meems, L.M.G., Artola Arita, V., Velt, M., Dudink, E.A.M.P., Crijns, H.J.G.M., Van Gelder, I.C., Rienstra, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914333/ https://www.ncbi.nlm.nih.gov/pubmed/35281756 http://dx.doi.org/10.1016/j.ijcha.2022.100987 |
Ejemplares similares
-
Gut-microbe derived TMAO and its association with more progressed forms of AF: Results from the AF-RISK study
por: Nguyen, B.O., et al.
Publicado: (2021) -
The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
por: Santema, Bernadet T., et al.
Publicado: (2019) -
Significance of NT-proBNP and High-Sensitivity Troponin in Friedreich Ataxia
por: Legrand, Lise, et al.
Publicado: (2020) -
Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023) -
Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
por: Santema, Bernadet T., et al.
Publicado: (2020)